• PDF: Delivered by email usually within 48 UK business hours.

Bausch & Lomb Incorporated Market Share Analysis

  • Publication Date:December 2010
  • Publisher:GlobalData
  • Product Type: Report
  • Pages:135

Bausch & Lomb Incorporated Market Share Analysis

GlobalData's new report, "Bausch & Lomb's Market Share Analysis"" provides in-depth information on Bausch & Lomb's market position in the different medical equipment markets it operates in. The report provides Bausch & Lomb's market share information in three market categories- Refractive Surgery Devices,Cataract Surgery Devices and Vision Care The report also provides data and information on the overall competitive landscape of the markets, the company operates in. The report is supplemented with global corporate-level profile with information on the company's business segments, major products and services, competitors, locations and subsidiaries, financial deals and other key developments.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

  • Global company shares (in Revenues) information for the key markets Bausch & Lomb Incorporated operates in - Ophthalmic Devices.
  • Bausch & Lomb's company shares (in Revenues) information for all the key countries the company has presence in - United States, Canada, Brazil, UK, Germany, France, Italy, Spain, Japan, China, India, and Australia.
  • Bausch & Lomb's company shares (in Revenues) information for all the key market categories the company has presence in - Refractive Surgery Devices,Cataract Surgery Devices and Vision Care.
  • All the key data-points are for 2009 and cover all the key regions - North America, Europe, Asia Pacific (APAC), Middle East and Africa (MEA) and South and Central America.
  • Global corporate-level profile with information on the company's business segments, major products and services, competitors, and locations and subsidiaries.
  • Comprehensive coverage of the latest financial deals involving the company and its subsidiaries, if any - Mergers & Acquisitions (M&A), Asset Transactions, PE/VC, Equity Offerings, Debt Offerings, and Partnerships.

Reasons to buy

  • Develop sales and marketing strategies by identifying who-stands-where in the markets Bausch & Lomb Incorporated operates in.
  • Plan your competition strategies by identifying the company's shares in the markets and geographic regions it operates in.
  • Design your own inorganic growth and business-collaboration strategies by understanding the financial deals your competitors are involved in.
  • Advance your understanding of the competitive landscape and the competitors by leveraging on the data and information provided in the report.
  • Support your overall business strategies by leveraging on the key data and information provided in the report, which includes but not limited to Bausch & Lomb's market positions.
  • 1 Table of Contents
    • 1.1 List of Tables
    • 1.2 List of Figures
  • 2 Introduction
    • 2.1 What Is This Report About?
  • 3 Definitions of Markets/Categories Covered
    • 3.1 Ophthalmic Devices
      • 3.1.1 Cataract Surgery Devices
      • 3.1.2 Ophthalmic Diagnostic Equipment
      • 3.1.3 Refractive Surgery Devices
      • 3.1.4 Vision Care
  • 4 Company Snapshot
    • 4.1 Key Information
    • 4.2 Company Overview
    • 4.3 SWOT Snapshot
  • 5 Business Description
    • 5.1 Business Overview
    • 5.2 Cataract and Vitreoretinal Surgery Product Category
      • 5.2.1 Overview
      • 5.2.2 Market View
      • 5.2.3 Key Strategies
    • 5.3 Pharmaceuticals Category
      • 5.3.1 Overview
      • 5.3.2 Key Strategies
    • 5.4 Vision Care Product Category
      • 5.4.1 Overview
      • 5.4.2 Market View
    • 5.5 Major Products and Services
      • 5.5.1 Overview
      • 5.5.2 Consumer Products:
      • 5.5.3 Eye Care Professional Products:
      • 5.5.4 Product ImagesBrands:Brands:
  • 6 History
  • 7 Business Strategy
  • 8 SWOT Analysis
    • 8.1 Overview
    • 8.2 Bausch & Lomb Incorporated Strengths
      • 8.2.1 Diversified Ophthalmic Devices Portfolio
      • 8.2.2 Strategic Collaborations
      • 8.2.3 Widespread Geographical Presence
      • 8.2.4 Strong Brand Name
    • 8.3 Bausch & Lomb Incorporated Weaknesses
      • 8.3.1 Product Call Backs
      • 8.3.2 Lawsuits
    • 8.4 Bausch & Lomb Incorporated Opportunities
      • 8.4.1 Market Growth in Emerging Economies
      • 8.4.2 Growing Aged Population
      • 8.4.3 Inorganic Growth Strategy
      • 8.4.4 Growth in Ophthalmic Sector
      • 8.4.5 Product Launches
    • 8.5 Bausch & Lomb Incorporated Threats
      • 8.5.1 Stiff Competition
      • 8.5.2 Stringent Government Regulations
      • 8.5.3 Industry Consolidation Challenges
  • 9 Competitors
  • 10 Competitive Landscape
    • 10.1 Ophthalmic Devices, Global, Company Share (%), 2009
  • 11 Bausch & Lomb Incorporated Medical Equipment Market Share Analysis
    • 11.1 Bausch & Lomb Incorporated, Ophthalmic Devices, Global, Market Share (2009)
    • 11.2 Bausch & Lomb Incorporated, Asia-Pacific, Market Share (2009)
    • 11.3 Bausch & Lomb Incorporated, Europe, Market Share (2009)
    • 11.4 Bausch & Lomb Incorporated, Middle East and Africa, Market Share (2009)
    • 11.5 Bausch & Lomb Incorporated, North America, Market Share (2009)
    • 11.6 Bausch & Lomb Incorporated, South and Central America, Market Share (2009)
  • 12 Bausch & Lomb Incorporated Medical Equipment Market Share Analysis by Category
    • 12.1 Bausch & Lomb Incorporated, Ophthalmic Devices, Global, Category Revenue Share (2009)
    • 12.2 Bausch & Lomb Incorporated, Asia-Pacific, Category Revenue Share (2009)
      • 12.2.1 Bausch & Lomb Incorporated, Australia, Category Revenue Share (2009)
      • 12.2.2 Bausch & Lomb Incorporated, China, Category Revenue Share (2009)
      • 12.2.3 Bausch & Lomb Incorporated, India, Category Revenue Share (2009)
      • 12.2.4 Bausch & Lomb Incorporated, Japan, Category Revenue Share (2009)
      • 12.2.5 Bausch & Lomb Incorporated, Other Asia-Pacific, Category Revenue Share (2009)
    • 12.3 Bausch & Lomb Incorporated, Europe, Category Revenue Share (2009)
      • 12.3.1 Bausch & Lomb Incorporated, France, Category Revenue Share (2009)
      • 12.3.2 Bausch & Lomb Incorporated, Germany, Category Revenue Share (2009)
      • 12.3.3 Bausch & Lomb Incorporated, Italy, Category Revenue Share (2009)
      • 12.3.4 Bausch & Lomb Incorporated, Spain, Category Revenue Share (2009)
      • 12.3.5 Bausch & Lomb Incorporated, United Kingdom, Category Revenue Share (2009)
      • 12.3.6 Bausch & Lomb Incorporated, Other Europe, Category Revenue Share (2009)
    • 12.4 Bausch & Lomb Incorporated, Middle East and Africa, Category Revenue Share (2009)
    • 12.5 Bausch & Lomb Incorporated, North America, Category Revenue Share (2009)
      • 12.5.1 Bausch & Lomb Incorporated, Canada, Category Revenue Share (2009)
      • 12.5.2 Bausch & Lomb Incorporated, United States, Category Revenue Share (2009)
    • 12.6 Bausch & Lomb Incorporated, South and Central America, Category Revenue Share (2009)
      • 12.6.1 Bausch & Lomb Incorporated, Brazil, Category Revenue Share (2009)
      • 12.6.2 Bausch & Lomb Incorporated, Other South and Central America, Category Revenue Share (2009)
  • 13 Key Employees
  • 14 Key Employee Biographies
  • 15 Locations And Subsidiaries
    • 15.1 Head Office
    • 15.2 Other Locations & Subsidiaries
  • 16 Financial Deals Landscape
    • 16.1 Bausch & Lomb Incorporated, Deals Volume Summary, 2005 to YTD 2010
  • 17 Bausch & Lomb Incorporated Detailed Deal Summary
    • 17.1 Asset Purchase
      • 17.1.1 Bausch & Lomb Acquires Soothe Emollient (Lubricant) Eye Drops From Alimera Sciences
      • 17.1.2 Bausch & Lomb Acquires Alimera's OTC Eye Care Product
    • 17.2 Venture Financing
      • 17.2.1 AcuFocus Secures $18 Million In Series D Financing
      • 17.2.2 eyeonics Secures $16.5 Million In Fourth Round Of Financing
      • 17.2.3 eyeonics Secures $16.2 million In Series E Preferred Stock Financing
    • 17.3 Private Equity
      • 17.3.1 New York State Common Retirement Fund Invests $15 Million In Bausch & Lomb
      • 17.3.2 Warburg Pincus Acquires Bausch & Lomb
    • 17.4 Partnerships
      • 17.4.1 Bausch & Lomb Signs Joint Venture Agreement With 20/10 PERFECT VISION
      • 17.4.2 Norwood EyeCare Signs An Agreement With Bausch & Lomb
      • 17.4.3 Bausch & Lomb Enters Into Agreement With Santen Pharmaceutical
      • 17.4.4 Advanced Medical Optics Enters Into Licensing Agreement With Bausch & Lomb
      • 17.4.5 CIBA Vision And Bausch & Lomb Enters Into Cross-License Agreement
    • 17.5 Equity Offering
      • 17.5.1 eyeonics Withdraws Its Initial Public Offering Of $86.25 Million
    • 17.6 Acquisition
      • 17.6.1 Bausch & Lomb Acquires eyeonics
      • 17.6.2 AcuFocus Receives Investment From Bausch & Lomb
  • 18 Recent Developments
    • 18.1 Strategy and Business Planning
      • 18.1.1 Dec 15, 2009: Bausch & Lomb Confirms Plans for Contact Lens Manufacturing Consolidation
      • 18.1.2 Apr 29, 2009: Bausch & Lomb Plans To Market Surgical Equipment To Eye Doctors In Japan
      • 18.1.3 Feb 02, 2009: Bausch & Lomb Plans To Expand In India
    • 18.2 Financial Announcements
      • 18.2.1 Aug 08, 2007: Bausch & Lomb Reports Q2 2007 Results
      • 18.2.2 Jul 24, 2007: Bausch & Lomb Declares Quarterly Dividend
      • 18.2.3 May 10, 2007: Bausch & Lomb Preliminary Q1 2007 Results
      • 18.2.4 May 01, 2007: Bausch & Lomb Declares Quarterly Dividend
      • 18.2.5 Mar 06, 2007: Bausch & Lomb Reports Preliminary Q4 And 2006 Results
      • 18.2.6 Feb 26, 2007: Bausch & Lomb Declares Quarterly Dividend
    • 18.3 Research And Development
      • 18.3.1 Jun 16, 2010: Bausch & Lomb And Lions Clubs Partner To Fight Childhood Blindness
    • 18.4 Corporate Communications
      • 18.4.1 Sep 09, 2010: Bausch + Lomb Appoints Daniel Wechsler As Global President, Pharmaceuticals
      • 18.4.2 Sep 02, 2010: Bausch + Lomb Appoints Michael Rowe As Corporate Vice President Of Human Resources
      • 18.4.3 Jun 21, 2010: Bausch + Lomb Appoints Rodney Unsworth As President Of Asia-Pacific
      • 18.4.4 Jun 20, 2010: Bausch + Lomb Names Rodney Unsworth As President, Asia-Pacific
      • 18.4.5 Jun 16, 2010: Bausch + Lomb Appoints Robert Grant As CEO And President Of Surgical Business
      • 18.4.6 Jun 16, 2010: Bausch + Lomb Appoints Robert Grant As CEO And President Of Surgical Business
      • 18.4.7 May 28, 2010: Bausch + Lomb Appoints Hideyuki Ashikaga As President Of Japanese Operations
      • 18.4.8 Mar 15, 2010: Bausch & Lomb Names Fred Hassan As Chairman, Brent Saunders As CEO
      • 18.4.9 Mar 10, 2010: Bausch & Lomb Names Dr. Robert Steffen As Director Of Clinical Affairs, Vision Care
      • 18.4.10 Dec 07, 2009: Bausch & Lomb Appoints Mohinder Merchea As Director Of Medical Affairs, North America, Vision Care
      • 18.4.11 Nov 12, 2009: Bausch & Lomb Elects Fred Hassan To Its Board
      • 18.4.12 Sep 23, 2009: Bausch & Lomb Appoints Kerry Clark And Robert Palmisano To Its Board
      • 18.4.13 Jun 01, 2009: Bausch & Lomb Japan Appoints Francisco Ascencion As Its President
      • 18.4.14 May 26, 2009: Bausch & Lomb Ireland Names Colum Honan As General Manager
      • 18.4.15 May 11, 2009: Bausch & Lomb Appoints Peter Valenti Global Vision Care President And Steven F. Robins As North American Vision Care President
      • 18.4.16 Apr 01, 2009: Bausch & Lomb Names Mitsuo Hirose As Chairman
      • 18.4.17 Mar 25, 2009: Bausch & Lomb Names Brian J. Harris As CFO And Corporate Vice President
      • 18.4.18 Mar 25, 2009: Bausch & Lomb Appoints Brian Harris As CFO And Corporate Vice President
      • 18.4.19 Jan 16, 2009: Bausch & Lomb Appoints President, North America, Vision Care
    • 18.5 Legal and Regulatory
      • 18.5.1 May 31, 2009: Bausch & Lomb Settles $250 Million In Fungus Infection Lawsuits
      • 18.5.2 Jun 20, 2008: Bausch & Lomb Sues Lexington Insurance
      • 18.5.3 May 21, 2008: Bausch & Lomb Sued In St. Clair County
      • 18.5.4 Aug 20, 2007: Bausch & Lomb And Alcon Settle Advertising Lawsuit
      • 18.5.5 Jul 02, 2007: Bausch & Lomb Sued By Parker Waichman
      • 18.5.6 Jun 26, 2007: Bausch & Lomb Files Suit Against Alcon
      • 18.5.7 Nov 06, 2006: Bausch & Lomb Receives FDA Warning Letter Related To Inspection At Greenville
    • 18.6 Government and Public Interest
      • 18.6.1 Jul 22, 2010: Bausch + Lomb Voluntarily Recalls PreserVision Eye Vitamin AREDS 2 Formula In US
      • 18.6.2 Jun 10, 2008: FDA Panel Recommends Stricter Contact Lens Labeling
    • 18.7 Product News
      • 18.7.1 Aug 31, 2010: Bausch + Lomb Releases Single-Use Vitreoretinal Asymmetric Peeling Forceps
      • 18.7.2 Aug 23, 2010: Bausch + Lomb Introduces Stellaris PC Vision Enhancement System For Retinal Surgery
      • 18.7.3 Aug 03, 2010: Bausch + Lomb Introduces Stellaris PC Vision Enhancement System
      • 18.7.4 May 17, 2010: Bausch + Lomb Receives FDA Approval To Market Crystalens AO In Quarter Diopter Steps
      • 18.7.5 Apr 15, 2010: Bausch + Lomb Receives NTIOL Classification From CMS For Crystalens AO
      • 18.7.6 Apr 09, 2010: Bausch & Lomb To Celebrate Tenth Anniversary Of Crystalens At ASCRS Annual Meeting
      • 18.7.7 Jan 04, 2010: Bausch & Lomb To Launch Crystalens Aspheric Optic (AO) Lens
      • 18.7.8 Mar 03, 2009: Bausch & Lomb To Develop Intraocular Lens Using Santen's Hydrophobic Acrylic Polymers
      • 18.7.9 Oct 23, 2008: Bausch & Lomb Highlights SofLens Daily Disposable Contact Lenses At American Academy Of Optometry Annual Meeting
      • 18.7.10 Sep 15, 2008: FDA Approves Bausch & Lomb Akreos Advanced Optics Aspheric Lens
      • 18.7.11 Apr 09, 2008: Interim results of hydrophilic acrylic IOL show good visual function, centration
      • 18.7.12 Apr 07, 2008: Bausch & Lomb Lens Wins 2008 Medical Design Excellence Awards Competition
      • 18.7.13 Apr 02, 2008: Gift Of Sight Given To 100 People In 100 Minutes
      • 18.7.14 Jan 18, 2007: Akreos MI-60 Lens European Launch
      • 18.7.15 Sep 01, 2006: Fluidics and Heat Generation of Alcon Infiniti and Legacy, Bausch & Lomb Millennium, and Advanced Medical Optics Sovereign Phacoemulsification Systems
      • 18.7.16 Aug 08, 2006: Bausch & Lomb Receives FDA Approval for Plasma Treatment of Gas-Permeable Contact Lenses
      • 18.7.17 Feb 23, 2006: Bausch & Lomb GP Materials Receive Expanded FDA Post-Surgical Indications
      • 18.7.18 Feb 23, 2006: BostonXO®, and EO Gas Permeable Contact Lenses Receive Clearance for Use Following Penetrating Keratoplasty or Refractive Surgeries
    • 18.8 Product Approvals
      • 18.8.1 May 17, 2010: Bausch + Lomb Receives FDA Approval To Market Crystalens AO In Quarter Diopter Steps
      • 18.8.2 Sep 15, 2008: FDA Approves Bausch & Lomb Akreos Advanced Optics Aspheric Lens
    • 18.9 Clinical Trials
      • 18.9.1 Apr 09, 2008: Interim results of hydrophilic acrylic IOL show good visual function, centration
    • 18.10 Other Significant Developments
      • 18.10.1 Aug 12, 2009: Bausch & Lomb Hires SMP Agency For Its EMEA Lens Care Business
  • 19 Appendix
    • 19.1 Research Methodology
    • 19.2 Secondary Research
    • 19.3 Primary Research
    • 19.4 Models
    • 19.5 Forecasts
    • 19.6 Expert Panels
    • 19.7 GlobalData Consulting
    • 19.8 Currency Conversion
    • 19.9 Contact Us
    • 19.10 Disclaimer
  • List of Tables
    • Table 1: Bausch & Lomb Incorporated, Key Facts, 2009
    • Table 2: Bausch & Lomb Incorporated, SWOT Analysis, 2009
    • Table 3: Ophthalmic Devices, Global, Company Share by Revenue ($m), 2009
    • Table 4: Bausch & Lomb Incorporated, Ophthalmic Devices, Global, Revenue ($m) and Market Share (%), 2009
    • Table 5: Bausch & Lomb Incorporated, Ophthalmic Devices, Asia-Pacific, Revenue ($m) and Market Share (%), 2009
    • Table 6: Bausch & Lomb Incorporated, Ophthalmic Devices, Europe, Revenue ($m) and Market Share (%), 2009
    • Table 7: Bausch & Lomb Incorporated, Ophthalmic Devices, Middle East and Africa, Revenue ($m) and Market Share (%), 2009
    • Table 8: Bausch & Lomb Incorporated, Ophthalmic Devices, North America, Revenue ($m) and Market Share (%), 2009
    • Table 9: Bausch & Lomb Incorporated, Ophthalmic Devices, South and Central America, Revenue ($m) and Market Share (%), 2009
    • Table 10: Bausch & Lomb Incorporated, Ophthalmic Devices, Global, Revenue ($m) and Market Share (%) by Category, 2009
    • Table 11: Bausch & Lomb Incorporated, Ophthalmic Devices, Asia-Pacific, Revenue ($m) and Market Share (%) by Category, 2009
    • Table 12: Bausch & Lomb Incorporated, Ophthalmic Devices, Australia, Revenue ($m) and Market Share (%) by Category, 2009
    • Table 13: Bausch & Lomb Incorporated, Ophthalmic Devices, China, Revenue ($m) and Market Share (%) by Category, 2009
    • Table 14: Bausch & Lomb Incorporated, Ophthalmic Devices, India, Revenue ($m) and Market Share (%) by Category, 2009
    • Table 15: Bausch & Lomb Incorporated, Ophthalmic Devices, Japan, Revenue ($m) and Market Share (%) by Category, 2009
    • Table 16: Bausch & Lomb Incorporated, Ophthalmic Devices, Other Asia-Pacific, Revenue ($m) and Market Share (%) by Category, 2009
    • Table 17: Bausch & Lomb Incorporated, Ophthalmic Devices, Europe, Revenue ($m) and Market Share (%) by Category, 2009
    • Table 18: Bausch & Lomb Incorporated, Ophthalmic Devices, France, Revenue ($m) and Market Share (%) by Category, 2009
    • Table 19: Bausch & Lomb Incorporated, Ophthalmic Devices, Germany, Revenue ($m) and Market Share (%) by Category, 2009
    • Table 20: Bausch & Lomb Incorporated, Ophthalmic Devices, Italy, Revenue ($m) and Market Share (%) by Category, 2009
    • Table 21: Bausch & Lomb Incorporated, Ophthalmic Devices, Spain, Revenue ($m) and Market Share (%) by Category, 2009
    • Table 22: Bausch & Lomb Incorporated, Ophthalmic Devices, United Kingdom, Revenue ($m) and Market Share (%) by Category, 2009
    • Table 23: Bausch & Lomb Incorporated, Ophthalmic Devices, Other Europe, Revenue ($m) and Market Share (%) by Category, 2009
    • Table 24: Bausch & Lomb Incorporated, Ophthalmic Devices, Middle East and Africa, Revenue ($m) and Market Share (%) by Category, 2009
    • Table 25: Bausch & Lomb Incorporated, Ophthalmic Devices, North America, Revenue ($m) and Market Share (%) by Category, 2009
    • Table 26: Bausch & Lomb Incorporated, Ophthalmic Devices, Canada, Revenue ($m) and Market Share (%) by Category, 2009
    • Table 27: Bausch & Lomb Incorporated, Ophthalmic Devices, United States, Revenue ($m) and Market Share (%) by Category, 2009
    • Table 28: Bausch & Lomb Incorporated, Ophthalmic Devices, South and Central America, Revenue ($m) and Market Share (%) by Category, 2009
    • Table 29: Bausch & Lomb Incorporated, Ophthalmic Devices, Brazil, Revenue ($m) and Market Share (%) by Category, 2009
    • Table 30: Bausch & Lomb Incorporated, Ophthalmic Devices, Other South and Central America, Revenue ($m) and Market Share (%) by Category, 2009
    • Table 31: Bausch & Lomb Incorporated, Key Employees
    • Table 32: Bausch & Lomb Incorporated, Other Locations
    • Table 33: Bausch & Lomb Incorporated, Subsidiaries
    • Table 34: Bausch & Lomb Incorporated, Deals Volume Summary, 2005 to YTD 2010
    • Table 35: Bausch & Lomb Incorporated, Deals Summary, 2005 to YTD 2010
    • Table 36: Bausch & Lomb Acquires Soothe Emollient (Lubricant) Eye Drops From Alimera Sciences
    • Table 37: Bausch & Lomb Acquires Alimera's OTC Eye Care Product
    • Table 38: AcuFocus Secures $18 Million In Series D Financing
    • Table 39: eyeonics Secures $16.5 Million In Fourth Round Of Financing
    • Table 40: eyeonics Secures $16.2 million In Series E Preferred Stock Financing
    • Table 41: New York State Common Retirement Fund Invests $15 Million In Bausch & Lomb
    • Table 42: Warburg Pincus Acquires Bausch & Lomb
    • Table 43: Bausch & Lomb Signs Joint Venture Agreement With 20/10 PERFECT VISION
    • Table 44: Norwood EyeCare Signs An Agreement With Bausch & Lomb
    • Table 45: Bausch & Lomb Enters Into Agreement With Santen Pharmaceutical
    • Table 46: Advanced Medical Optics Enters Into Licensing Agreement With Bausch & Lomb
    • Table 47: CIBA Vision And Bausch & Lomb Enters Into Cross-License Agreement
    • Table 48: eyeonics Withdraws Its Initial Public Offering Of $86.25 Million
    • Table 49: Bausch & Lomb Acquires eyeonics
    • Table 50: AcuFocus Receives Investment From Bausch & Lomb
    • Table 51: USD to Local Currency, Average Exchange Rate 2009
  • List of Figures
    • Figure 1: Ophthalmic Devices, Global, Company Share (%), 2009
    • Figure 2: Bausch & Lomb Incorporated, Ophthalmic Devices, Global, Market Share (%), 2009
    • Figure 3: Bausch & Lomb Incorporated, Ophthalmic Devices, Asia-Pacific, Market Share (%), 2009
    • Figure 4: Bausch & Lomb Incorporated, Ophthalmic Devices, Europe, Market Share (%), 2009
    • Figure 5: Bausch & Lomb Incorporated, Ophthalmic Devices, North America, Market Share (%), 2009
    • Figure 6: Bausch & Lomb Incorporated, Ophthalmic Devices, South and Central America, Market Share (%), 2009
    • Figure 7: Bausch & Lomb Incorporated, Ophthalmic Devices, Global, Category Revenue Share (%), 2009
    • Figure 8: Bausch & Lomb Incorporated, Ophthalmic Devices, Global, Market Share (%) by Category, 2009
    • Figure 9: Bausch & Lomb Incorporated, Ophthalmic Devices, Asia-Pacific, Category Revenue Share (%), 2009
    • Figure 10: Bausch & Lomb Incorporated, Ophthalmic Devices, Asia-Pacific, Market Share (%) by Category, 2009
    • Figure 11: Bausch & Lomb Incorporated, Ophthalmic Devices, Australia, Category Revenue Share (%), 2009
    • Figure 12: Bausch & Lomb Incorporated, Ophthalmic Devices, Australia, Market Share (%) by Category, 2009
    • Figure 13: Bausch & Lomb Incorporated, Ophthalmic Devices, China, Category Revenue Share (%), 2009
    • Figure 14: Bausch & Lomb Incorporated, Ophthalmic Devices, China, Market Share (%) by Category, 2009
    • Figure 15: Bausch & Lomb Incorporated, Ophthalmic Devices, India, Category Revenue Share (%), 2009
    • Figure 16: Bausch & Lomb Incorporated, Ophthalmic Devices, India, Market Share (%) by Category, 2009
    • Figure 17: Bausch & Lomb Incorporated, Ophthalmic Devices, Japan, Category Revenue Share (%), 2009
    • Figure 18: Bausch & Lomb Incorporated, Ophthalmic Devices, Japan, Market Share (%) by Category, 2009
    • Figure 19: Bausch & Lomb Incorporated, Ophthalmic Devices, Other Asia-Pacific, Category Revenue Share (%), 2009
    • Figure 20: Bausch & Lomb Incorporated, Ophthalmic Devices, Other Asia-Pacific, Market Share (%) by Category, 2009
    • Figure 21: Bausch & Lomb Incorporated, Ophthalmic Devices, Europe, Category Revenue Share (%), 2009
    • Figure 22: Bausch & Lomb Incorporated, Ophthalmic Devices, Europe, Market Share (%) by Category, 2009
    • Figure 23: Bausch & Lomb Incorporated, Ophthalmic Devices, France, Category Revenue Share (%), 2009
    • Figure 24: Bausch & Lomb Incorporated, Ophthalmic Devices, France, Market Share (%) by Category, 2009
    • Figure 25: Bausch & Lomb Incorporated, Ophthalmic Devices, Germany, Category Revenue Share (%), 2009
    • Figure 26: Bausch & Lomb Incorporated, Ophthalmic Devices, Germany, Market Share (%) by Category, 2009
    • Figure 27: Bausch & Lomb Incorporated, Ophthalmic Devices, Italy, Category Revenue Share (%), 2009
    • Figure 28: Bausch & Lomb Incorporated, Ophthalmic Devices, Italy, Market Share (%) by Category, 2009
    • Figure 29: Bausch & Lomb Incorporated, Ophthalmic Devices, Spain, Category Revenue Share (%), 2009
    • Figure 30: Bausch & Lomb Incorporated, Ophthalmic Devices, Spain, Market Share (%) by Category, 2009
    • Figure 31: Bausch & Lomb Incorporated, Ophthalmic Devices, United Kingdom, Category Revenue Share (%), 2009
    • Figure 32: Bausch & Lomb Incorporated, Ophthalmic Devices, United Kingdom, Market Share (%) by Category, 2009
    • Figure 33: Bausch & Lomb Incorporated, Ophthalmic Devices, Other Europe, Category Revenue Share (%), 2009
    • Figure 34: Bausch & Lomb Incorporated, Ophthalmic Devices, Other Europe, Market Share (%) by Category, 2009
    • Figure 35: Bausch & Lomb Incorporated, Ophthalmic Devices, Middle East and Africa, Category Revenue Share (%), 2009
    • Figure 36: Bausch & Lomb Incorporated, Ophthalmic Devices, Middle East and Africa, Market Share (%) by Category, 2009
    • Figure 37: Bausch & Lomb Incorporated, Ophthalmic Devices, North America, Category Revenue Share (%), 2009
    • Figure 38: Bausch & Lomb Incorporated, Ophthalmic Devices, North America, Market Share (%) by Category, 2009
    • Figure 39: Bausch & Lomb Incorporated, Ophthalmic Devices, Canada, Category Revenue Share (%), 2009
    • Figure 40: Bausch & Lomb Incorporated, Ophthalmic Devices, Canada, Market Share (%) by Category, 2009
    • Figure 41: Bausch & Lomb Incorporated, Ophthalmic Devices, United States, Category Revenue Share (%), 2009
    • Figure 42: Bausch & Lomb Incorporated, Ophthalmic Devices, United States, Market Share (%) by Category, 2009
    • Figure 43: Bausch & Lomb Incorporated, Ophthalmic Devices, South and Central America, Category Revenue Share (%), 2009
    • Figure 44: Bausch & Lomb Incorporated, Ophthalmic Devices, South and Central America, Market Share (%) by Category, 2009
    • Figure 45: Bausch & Lomb Incorporated, Ophthalmic Devices, Brazil, Category Revenue Share (%), 2009
    • Figure 46: Bausch & Lomb Incorporated, Ophthalmic Devices, Brazil, Market Share (%) by Category, 2009
    • Figure 47: Bausch & Lomb Incorporated, Ophthalmic Devices, Other South and Central America, Category Revenue Share (%), 2009
    • Figure 48: Bausch & Lomb Incorporated, Ophthalmic Devices, Other South and Central America, Market Share (%) by Category, 2009
    • Figure 49: Bausch & Lomb Incorporated, Deals Volume Summary, 2005 to YTD 2010
+44 20 8816 8548

Ask a question about Bausch & Lomb Incorporated Market Share Analysis

Enter the characters you see in the picture below
Captcha